How AI Is Helping Diagnose Disease | Chuck Piccirillo

How AI Is Helping Diagnose Disease | Chuck Piccirillo

Technology can make healthcare more sophisticated. The harder question is whether it actually makes healthcare better for the patient.

Chuck Piccirillo, CEO of Zealic Health, joins BioTalk Unzipped to discuss patient-centered digital health, entrepreneurship, artificial intelligence, regulation, and the personal experience that helped shape his career.

Chuck shares his experience living with colitis and how it influenced his desire to improve healthcare from the patient’s perspective. He explains how Zealic Health approaches digital platforms intended to create more individualized care experiences.

The conversation then turns unexpectedly geopolitical. Chuck describes how the war in Ukraine affected his organization and how the company worked to relocate employees to Poland.

In New News, the discussion tackles the FDA’s final rule involving laboratory-developed tests and the debate surrounding regulation of LDTs as medical devices.

Gregory, Chad, and Chuck examine the difficult balance between protecting patients and creating regulatory uncertainty that may complicate innovation.

The episode closes with AI and diagnostics. Where can artificial intelligence genuinely improve medical decision-making, and where does marketing run ahead of evidence?

The larger question is not whether AI will enter healthcare. It is how healthcare can use it responsibly while keeping clinicians and patients at the center.

Chapters

01:33 - Introduction and background

04:03 - The Crohn’s & Colitis Foundation and Chuck’s experience with colitis

07:49 - Patient-centric healthcare and Zealic Health

13:26 - Plan B: Moving operations from Ukraine to Poland

20:02 - New News: The controversy surrounding LDTs as medical devices

27:20 - Healthcare regulation and its implications for AI

30:07 - How AI can assist medical diagnosis

Crohn’s & Colitis Foundation

https://www.crohnscolitisfoundation.org/

Connect with Chuck Piccirillo

Chuck Piccirillo

https://www.linkedin.com/in/cpiccirillo/

Zealic Health

http://www.zealichealth.com

Connect with the hosts

Dr. Chad Briscoe

https://www.linkedin.com/in/chadbriscoe/

Gregory Austin

https://www.linkedin.com/in/gregoryaustin1/

New News

House committee tells FDA to suspend lab-developed test rule:

https://www.healthcaredive.com/news/house-committee-fda-suspend-ldt-rule/721362/

Image credits

Crohn’s & Colitis Foundation: https://www.crohnscolitisfoundation.org/

FDA/LDT: https://x.com/FDADeviceInfo/status/1784965525522493657

U.S. Capitol: https://worldstrides.com/blog/2013/07/u-s-capitol/

Healthcare costs: https://www.freepik.com/photos/increasing-costs

Cancer patient: https://www.freepik.com/free-photo/sick-asian-man-sitting-chair-side-view_33753979.htm

Computer-aided diagnosis: https://researchoutreach.org/articles/assessing-performances-computer-aided-diagnosis-breast-cancer/

Keywords

digital health, patient engagement, patient-centric healthcare, artificial intelligence, AI diagnostics, laboratory-developed tests, FDA regulation, decentralized clinical trials, healthcare technology

#BioTalkUnzipped #DigitalHealth #AIinHealthcare #FDA #PatientCare #Biotechnology #MedicalDevice

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(45)

Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

Why is gene therapy still so difficult to manufacture at scale after decades of progress?Phillip Ramsey, Chief Technical Officer at Sangamo Therapeutics, joins BioTalk Unzipped for a candid conversati...

8 Elo 11min

Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

A mother’s search for answers to her daughter’s relentless brain tumor led her into natural killer cell biology, cancer immunotherapy, and biotech entrepreneurship.Sponsored by Leucentra, https://leuc...

20 Heinä 1h 4min

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

Oncology drug development is becoming more complex, and bioanalysis can no longer be treated as simple drug measurement.Sponsored by Leucentra, https://leucentra.com/Inspired by science, empowered by ...

11 Kesä 29min

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Can artificial intelligence help make cancer therapies safer, more targeted, and more effective?In this episode of BioTalk Unzipped, Gregory Austin sits down with Dr. Daniel Reker, Assistant Professor...

25 Huhti 50min

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why haven’t we cured cancer yet? A Genentech scientist explains the real reason.In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Bob Liu, Senior Principal Sci...

19 Maalis 1h

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

Recorded October 31, 2025In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Kate Neville, immunologist turned seasoned biotech patent attorney at Marshall, Gers...

16 Helmi 52min

Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins

Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins

In this episode of BioTalk Unzipped, hosts Gregory Austin and Dr. Chad Briscoe sit down with Glafabra CEO: Dr. Chris Hopkins, geneticist, biochemist, and biotech entrepreneur, to explore the science a...

22 Joulu 202549min

Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Binodh DeSilva, Senior Vice President of Bioanalysis at Ultragenyx Pharmaceutical, to explore the science and...

23 Loka 202531min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
psykopodiaa-podcast
rss-rahapodi
hyva-paha-johtaminen
rss-inderes
rss-ammattipodcast
rss-porssipuhetta
ostan-asuntoja-podcast
pomojen-suusta
rss-karon-grilli
sijoituspodi
rss-sami-miettinen-neuvottelija
rss-laakispodi
rahapuhetta
oppimisen-psykologia
rss-hilden-kaira
rss-pariisilaiset
inderespodi
rss-porssipodi